Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) Clarification on European Regulatory Status of LENTIGLOBIN™

LONDON, 27-Mar-2019 — /EuropaWire/ — The LentiGlobin application for Conditional Marketing Authorization (cMAA) at the EMA from bluebird bio is still in the process of being reviewed by CHMP during their 25-28 March 2019 meeting. An opinion for the cMAA is expected to be released soon.

CONTACT INFORMATION

AVLT
Dr. Michele Lipucci di Paola
+39 3382104475
mlipucci@yahoo.com

UKTS
Dr. Chris Sotirelis
+44 7979594067
chris.sotirelis@gmail.com

Logos:

AVLT logo

UKTS logo

MORE ON GENE THERAPY:

EDITOR'S PICK:

Comments are closed.